Hostname: page-component-76fb5796d-vfjqv Total loading time: 0 Render date: 2024-04-26T06:31:08.630Z Has data issue: false hasContentIssue false

COVID-19 testing trends: pre-radiation and throughout cancer care

Published online by Cambridge University Press:  03 March 2022

Ian Messing
Affiliation:
The George Washington University, School of Medicine and Health Sciences, Washington, DC, USA
Miriam Felps
Affiliation:
The George Washington University, Division of Radiation Oncology, Washington, DC, USA
Sharad Goyal
Affiliation:
The George Washington University, School of Medicine and Health Sciences, Washington, DC, USA The George Washington University, Division of Radiation Oncology, Washington, DC, USA
Yuan James Rao
Affiliation:
The George Washington University, School of Medicine and Health Sciences, Washington, DC, USA The George Washington University, Division of Radiation Oncology, Washington, DC, USA
Katherine Schreiner
Affiliation:
The George Washington University, School of Medicine and Health Sciences, Washington, DC, USA
Diana Scully
Affiliation:
The George Washington University, Division of Radiation Oncology, Washington, DC, USA
Martin Ojong-Ntui
Affiliation:
The George Washington University, School of Medicine and Health Sciences, Washington, DC, USA The George Washington University, Division of Radiation Oncology, Washington, DC, USA
Minh-Phuong Huynh-Le*
Affiliation:
The George Washington University, School of Medicine and Health Sciences, Washington, DC, USA The George Washington University, Division of Radiation Oncology, Washington, DC, USA
*
Author for correspondence: Minh-Phuong Huynh-Le, The George Washington University, School of Medicine and Health Sciences, Washington, DC, USA. E-mail: mhuynhle@gmail.com

Abstract

Introduction:

Patients presenting for radiation therapy (RT) at a single institution were analysed regarding treatment delays and disparities during the coronavirus disease 2019 (COVID-19) pandemic.

Methods:

The study was conducted at an urban multidisciplinary cancer centre. In April 2020, the institution’s radiation oncology department implemented universal COVID-19 screening protocols prior to RT initiation. COVID-19 testing information on cancer patients planned for RT from 04/2020 to 01/2021 was reviewed. Trends of other lifetime COVID-19 testing and overall care delays were also studied.

Results:

Two hundred and fifty-four consecutive cancer patients received RT. Median age was 63 years (range 24–94) and 57·9% (n = 147) were Black. Most (n = 107, 42·1%) patients were insured through Medicare. 42·9% (n = 109) presented with stage IV disease. One (0·4%) asymptomatic patient tested positive for COVID-19 pre-RT. The cohort received 975 lifetime COVID-19 tests (median 3 per patient, range 1–18) resulting in 29 positive test results across 21 patients. Sixteen patients had RT delays. Identifying as Hispanic/Latino was associated with testing positive for COVID-19 (p = 0·015) and RT delay (p = 0·029).

Conclusion:

Most patients with cancer planned for RT tested negative for COVID-19 and proceeded to RT without delay. However, increased testing burden, delays in diagnostic workup and testing positive for COVID-19 may intensify disparities affecting this urban patient population.

Type
Original Article
Copyright
© The Author(s), 2022. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

News Room. Coronavirus. https://coronavirus.dc.gov/newsroom. Published 2020. Accessed on 12th July 2021.Google Scholar
COVID-19 Surveillance. Coronavirus. http://coronavirus.dc.gov/data. Published 2020. Accessed on 12th July 2021.Google Scholar
American Society for Radiation Oncology. COVID-19 recommendations and information. http://astro.org/Daily-Practice/COVID-19-Recommendations-and-Information/Clinical-Guidance. Published 2020. Accessed on 12th July 2021.Google Scholar
Zaorsky, N G, Yu, J B, McBride, S M et al. Prostate cancer radiation therapy recommendations in response to COVID-19. Adv Radiat Oncol 2020; 5 (4): 659665.CrossRefGoogle ScholarPubMed
Liang, W, Guan, W, Chen, R et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020; 21 (3): 335337.CrossRefGoogle ScholarPubMed
Kuderer, N M, Choueiri, T K, Shah, D P et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet 2020; 396 (10253): 758.Google Scholar
Killerby, M E, Link-Gelles, R, Haight, S C et al. Characteristics associated with hospitalization among patients with COVID-19 – Metropolitan Atlanta, Georgia, March–April 2020. MMWR Morb Mortal Wkly Rep 2020; 69 (25): 790794.CrossRefGoogle ScholarPubMed
Siegel, R L, Miller, K D, Jemal, A. Cancer statistics, 2020. CA Cancer J Clin 2020; 70 (1): 730.CrossRefGoogle ScholarPubMed
Hanna, T P, King, W D, Thibodeau, S et al. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ 2020; 371: m4087.CrossRefGoogle ScholarPubMed
COVID-19 Surveillance. Coronavirus. https://coronavirus.dc.gov/data. Published 2020. Accessed on 12th July 2021.Google Scholar
Centers for Disease Control and Prevention. Han Archive – 00429, 2020. https://emergency.cdc.gov/han/2020/HAN00429.asp. Accessed on 12th July 2021.Google Scholar
Huang, Q, Hu, S, Ran, F M et al. Asymptomatic COVID-19 infection in patients with cancer at a cancer-specialized hospital in Wuhan, China – preliminary results. Eur Rev Med Pharmacol Sci 2020; 24 (18): 97609764.Google Scholar
Harris, P A, Taylor, R, Thielke, R, Payne, J, Gonzalez, N, Conde, J G. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42 (2): 377381.CrossRefGoogle ScholarPubMed
Centers for Disease Control and Prevention. COVID-19 pandemic planning scenarios. http://cdc.gov/coronavirus/2019-ncov/hcp/planning-scenarios.html. Published 2020. Accessed on 12th July 2021.Google Scholar
He, X, Lau, E H Y, Wu, P et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med 2020; 26 (9): 14911493.CrossRefGoogle ScholarPubMed
Yanes-Lane, M, Winters, N, Fregonese, F et al. Proportion of asymptomatic infection among COVID-19 positive persons and their transmission potential: a systematic review and meta-analysis. PLoS One 2020; 15 (11): e0241536.CrossRefGoogle ScholarPubMed
Cheng, H Y, Jian, S W, Liu, D P et al. Contact tracing assessment of COVID-19 transmission dynamics in Taiwan and risk at different exposure periods before and after symptom onset. JAMA Intern Med 2020; 180 (9): 1264.CrossRefGoogle ScholarPubMed
Ning, M S, McAleer, M F, Jeter, M D et al. Mitigating the impact of COVID-19 on oncology: clinical and operational lessons from a prospective radiation oncology cohort tested for COVID-19. Radiother Oncol 2020; 148: 252257.CrossRefGoogle ScholarPubMed
Marschner, S, Corradini, S, Rauch, J et al. SARS-CoV-2 prevalence in an asymptomatic cancer cohort – results and consequences for clinical routine. Radiat Oncol 2020; 15 (1): 165.CrossRefGoogle Scholar
Modi, C, Dragun, A E, Henson, C F et al. A statewide multi-institutional study of asymptomatic pretreatment testing of radiation therapy patients for SARS-CoV-2 in a high-incidence region of the United States. Adv Radiat Oncol 2021; 6 (4): 100704.CrossRefGoogle Scholar
Huang, J, Barbera, L, Brouwers, M et al. Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol 2003; 21 (7): 1424.CrossRefGoogle ScholarPubMed
Irwin, C, Hunn, M, Purdie, G, Hamilton, D. Delay in radiotherapy shortens survival in patients with high grade Glioma. J Neurooncol 2007; 85 (3): 339343.CrossRefGoogle ScholarPubMed
Ohri, N, Rapkin, B D, Guha, C, Kalnicki, S, Garg, M. Radiation therapy noncompliance and clinical outcomes in an urban academic cancer center. Int J Radiat Oncol Biol Phys 2016; 95 (2): 563570.CrossRefGoogle Scholar
Hanna, T P, King, W D, Thibodeau, S et al. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ 2020; 371: m4087.CrossRefGoogle ScholarPubMed
Onder, G, Rezza, G, Brusaferro, S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA 2020; 323 (16): 1619.Google ScholarPubMed
Al-Shamsi, H O, Coomes, E A, Aldhaheri, K, Alrawi, S. Serial screening for COVID-19 in asymptomatic patients receiving anticancer therapy in the United Arab Emirates. JAMA Oncol 2021; 7 (1): 129131.CrossRefGoogle ScholarPubMed
Teckie, S, Andrews, J Z, Chen, W C et al. Impact of the COVID-19 pandemic surge on radiation treatment: report from a multicenter New York area institution. JCO Oncol Pract 2021; 17 (9): e1270e1277.CrossRefGoogle ScholarPubMed
Centers for Disease Control and Prevention. Risk for COVID-19 infection, hospitalization, and death by race/ethnicity. https:/cdc.gov/coronavirus/2019-ncov/covid-data/investigations-discovery/hospitalization-death-by-race-ethnicity.html. Published 2020. Accessed on 12th July 2021.Google Scholar
Muñoz-Price, L S, Nattinger, A B, Rivera, F et al. Racial disparities in incidence and outcomes among patients with COVID-19. JAMA Netw Open 2020; 3 (9): e2021892.CrossRefGoogle ScholarPubMed
Gu, T, Mack, J A, Salvatore, M et al. Characteristics associated with racial/ethnic disparities in COVID-19 outcomes in an academic health care system. JAMA Netw Open 2021; 4 (8): e2126218.Google Scholar
Pan, D, Sze, S, Minhas, J S et al. The impact of ethnicity on clinical outcomes in COVID-19: a systematic review. EClinical Medicine 2020; 23: 100404.CrossRefGoogle ScholarPubMed